RV Group Pharmaceuticals

World Class Manufacturing Facilities

RV Group Pharmaceuticals based out of Singapore is a dominant player in Asia with offices in India, Vietnam, the Philippines and Canada.

OBJECTIVE

RVLL (India) is EU GMP approved manufacturing units of RV Group. At RVLL, we manufacture general oral solid dosage form i.e. Tablets and Capsules. RVLL has a dedicated EU approved manufacturing line for colored products with a focus on Rifaximin Tablets. We are open for new business opporunties for other colored line products.
RV-OPV is EU-GMP Standard Unit. At RV-OPV, we manufacture non-hormonal, non-cephalosporin, non-oncological and non toxical oral dosage forms. We have all three presentation in Capsules, Tablets and Sachets. RV-OPV has over 300 products in the therapeutic segments of GI, CV, Respiratory, Anti Infectives and many more. We are looking forward to partner with manufacturing and/or distribution companies, who would bring our manufactured products to their countries of operations like in EU, Middle Eastern, African and Asian countries.
RV Group Philippines is engaged in sales, marketing and distribution of pharmaceuticals, medical devices food supplements and cosmetics nationwide; we offer a strategic partnership for companies looking to enter or strengthen their presence in the Philippines market. Our extensive local knowledge, established network, and commitment to excellence make us an ideal partner. We invite manufacturers and distributors to collaborate with us and unlock new opportunities for growth in this dynamic market.

RVLL ACCREDITATIONS

RVOPV ACCREDITATIONS

Regulatory Compliance

We are committed to complying with all applicable regulatory requirements in Europe.

Regulatory Authorities

We work closely with regulatory authorities in Europe, including the European Medicines Agency (EMA) and national regulatory bodies, to ensure compliance with all relevant regulations.

Compliance Programs

We have established comprehensive compliance programs to ensure adherence to all applicable laws, regulations, and ethical standards.

Quality Management Systems

OUR PRODUCTS

No Generic Name Strength Dosage Form Therapeutic Segment Markets
1 Acetylcysteine 200mg (sachet 2g) Sachets Mucolytic Emerging
2 Acrivastine 8 mg Capsules Antihistamine Regulated & emerging
3 Alendronic acid 70 mg Tablets Bone resorption inhibitor Emerging
4 Ambroxol hydrochloride 20 mg Tablets Mucolytic Emerging
5 Amlodipine 5mg, 10 mg Tablets Antihypertensive Emerging
6 Arginine hcl 1g/5ml Syrup Amino acid Emerging
7 Ascorbic acid (as vit c 95%) 500mg Tablets Vitamin Emerging
8 Ascorbic acid (Vit C) 200mg/10ml Syrup Vitamin Emerging
9 Atorvastatin 10mg, 20 mg Tablets Antihyperlipidemic Emerging
10 Azithromycin 500mg Tablets Antibiotic Emerging
11 Benzalkonium chloride 1mg Tablets Antiseptic Emerging
12 Bismuth subsalicylate 525mg (15ml) Suspension Antidiarrheal agents Emerging
13 Bismuth subsalicylate 262mg Tablets Antidiarrheal agents Emerging
14 Calcium carbonate, vit d3 1250mg, 400 iu (sachet 2.5g) Sachets Calcium carbonate, vit d3 Emerging
15 Celecoxib 100 mg, 200 mg Capsules Anti-inflammatory Regulated & emerging
16 Ciprofloxacin 500mg Tablets Antibiotic Emerging
17 Clarithromycin 250mg, 500mg Tablets Antibiotic Emerging
18 Desloratadine 15mg/30ml Oral solution Antihistamine Regulated & emerging
19 Dextromethorphan hbr 15mg Tablets Antitussive Emerging
20 Dextromethorphan hbr, hzo benzcain 5mg, 7.5 mg Tablets Antitussive Emerging
21 Diacerein 50mg Capsules Anti-inflammatory Emerging
22 Dimethicone + guaiazulene 3000mg + 4mg (sachet 10g) Sachets Anti-inflammatory/skin protectant Emerging
23 Esomeprazole caps 40mg Capsules Proton pump inhibitor Emerging
24 Etodolac 200mg Tablets NSAID Emerging
25 Febuxostat 80mg, 40 mg Tablets Antigout Emerging
26 Fexofenadine hcl 60mg Tablets Antihistamine Emerging
27 Flurbiprofen 100mg Tablets NSAID Emerging
28 Fosfomycin 3 gm Sachets Antibiotics Regulated & Emerging
29 Glucosamine sulfate 2kcl + chondroitine sulfate sodium 750mg + 300mg Tablets Joint pain and osteoarthritis Emerging
30 Ibuprofen 200mg Tablets NSAID Emerging
31 Ibuprofen 100mg/5ml Oral suspension NSAID Regulated & emerging
32 Iron (as iron iii) hydroxide polymaltose complex 100mg (10ml), 1500mg (30ml) Syrup Haematinic Emerging
33 Itopride hcl 50 mg Tablets Antidiarrheal agents Emerging
34 Ivermectin 6mg Tablets Antiparasitic agent Emerging
35 Levosulpiride 25mg Capsules Antipsychotic Emerging
36 Lisinopril 10 mg Tablets Antihypertensive Emerging
37 L-Ornithine-L-Aspartate 3g (sachet 5g) Sachets Hepatoprotective Emerging
38 Magnesium gluconate, Calcium Glycerophosphate 426mg, 456mg Syrup Mineral Supplement Emerging
39 Magnesium Lactate Dih2o, Pyridoxine Hcl 470mg, 5mg Tablets Mineral Supplement Emerging
40 Montelukast 4mg Sachets Bronchodilators Regulated & Emerging
41 Montelukast 10mg, 4mg, 5mg Tablets Bronchodilators Emerging
42 Naproxen 200mg, 500mg Tablets NSAID Emerging
43 Omeprazole + Sodium Bicarbonate 20mg + 1680mg Sachets Proton-Pump Inhibitors Regulated & Emerging
44 Omeprazole Caps 20mg Capsules Proton Pump Inhibitor Emerging
45 Oxomemazine Guaifenesin 19.8mg/60ml, 399.6mg/60ml Syrup Antihistamine Emerging
46 Paracetamol 150mg (sachet 1.5g), 80mg (sachet 1.5g) Sachets Analgesic And Antipyretic Emerging
47 Paracetamol 500mg + 650mg Tablets Analgesic And Antipyretic Emerging
48 Paracetamol Phenylephrine Hcl Chlorpheniramine Mal. 160mg/5ml, 2.5mg/5ml, 1.0mg/5ml Syrup Cold And Flu Emerging
49 Paracetamol Powder For Oral Solution 150mg, 200mg Sachets Analgesic And Antipyretic Regulated & Emerging
No Generic Name BE Dosage Form Therapeutic Segment Markets
1 Apixaban 5.0 Mg Tablets Anti-Coagulant Regulated & Emerging
2 Apixaban 2.5 Mg BW Tablets Anti-Coagulant Regulated & Emerging
3 Azithromycin 500 Mg Tablets Anti-Biotics Emerging
4 Azithromycin 250 Mg Tablets Anti-Biotics Emerging
5 Ciprofibrate 100 Mg Tablets Anti-Lipidemic Emerging
6 Deferiprone 500 Mg Capsules Iron-Chelator Emerging
7 Dolutegravir 50 Mg Tablets Anti-Retroviral Regulated, Emerging & WHO PQ
8 Entecavir 1 Mg Tablets Anti-Retroviral Regulated, Emerging & WHO PQ
9 Entecavir 0.5 Mg Tablets Anti Retroviral Regulated, Emerging & WHO PQ
10 Esomeprazole Magnesium 40 Mg Delayed Release Capsules Proton Pump Inhibitor Emerging
11 Empagliflozin 25 Mg Tablets Anti-Diabetic Regulated & Emerging
12 Empagliflozin 10 Mg Tablets Anti-Diabetic Regulated & Emerging
13 Febuxostat 80 Mg Tablets Anti-Gout Emerging
14 Febuxostat 40 Mg BW Tablets Anti-Gout Emerging
15 Hydroxychloroquine Sulphate 200 Mg Tablets Anti-Malarial Emerging
16 Linagliptin 5 Mg Tablets Anti-Diabetic Regulated & Emerging
17 Metformin 1000 Mg Prolonged Release Tablets Anti-Diabetic Regulated & Emerging
18 Metformin 750 Mg Prolonged Release Tablets Anti-Diabetic Regulated & Emerging
19 Metformin 500 Mg Prolonged Release Tablets Anti-Diabetic Regulated & Emerging
20 Moxifloxacin 400 Mg BW Tablets Anti Bacterial Emerging
21 Obeticholic Acid 10 Mg Tablets Biliary Cholangitis Emerging
22 Obeticholic Acid 5 Mg Tablets Biliary Cholangitis Emerging
23 Paracetamol 650 Mg BW Tablets Anti-Pyretic Emerging
24 Paracetamol 500 Mg BW Tablets Anti-Pyretic Emerging
25 Pregabalin 75 Mg Capsules Neuropathic Pain Regulated & Emerging
26 Rifaximin 550 Mg In Process Tablets Ibs/ Hepatic Encephalopathy Regulated & Emerging
27 Rifaximin 400 Mg TBD Tablets Traveler's Diarrhea Regulated & Emerging
28 Rifaximin 200 Mg In Process Tablets Traveler's Diarrhea Regulated & Emerging
29 Rivaroxaban 20 Mg Tablets Anti-Coagulant Regulated & Emerging
30 Rivaroxaban 15 Mg BW Tablets Anti-Coagulant Regulated & Emerging
31 Rivaroxaban 10 Mg Tablets Anti-Coagulant Regulated & Emerging
32 Rivaroxaban 2.5 Mg BW Tablets Anti-Coagulant Regulated & Emerging
33 Sitagliptin 50 Mg + Metformin 1000 Mg Tablets IR Anti-Diabetic Regulated & Emerging
34 Sitagliptin 50 Mg + Metformin 850 Mg Tablets IR Anti-Diabetic Regulated & Emerging
35 Sitagliptin 50 Mg + Metformin 500 Mg BW Tablets IR Anti-Diabetic Regulated & Emerging
36 Sitagliptin 100 Mg Tablets Anti-Diabetic Emerging
37 Sitagliptin 50 Mg Tablets Anti-Diabetic Emerging
38 Sofosbuvir 400 Mg Tablets Anti Viral Emerging
39 Tenofovir Alafenamide 25 Mg Tablets Anti-Retroviral Regulated & Emerging
40 Tenofovir Disoproxil Fumarate 300 Mg Tablets Anti-Retroviral Emerging
41 Tenofovir Disoproxil Fumarate 300 Mg + Emtricitabine 200 Mg Tablets Anti-Retroviral Emerging
42 Tenofovir Disoproxil Fumarate 300 Mg + Lamivudine 100 Mg Tablets Anti-Retroviral Emerging
43 Tenofovir Disoproxil Fumarate 300 Mg + Lamivudine 300 Mg + Efavirenz 600 Mg Tablets Anti-Retroviral Emerging
44 Ticagrelor 90 Mg Tablets Anti-Platelet Regulated & Emerging
45 Ticagrelor 60 Mg BW Tablets Anti-Platelet Regulated & Emerging
46 Triclabendazole 250 Mg Tablets Anthelmintics, Fascioliasis And Paragonimiasis Emerging
Markets: Emerging Regulated & Emerging + WHO PQ  ·  BE: Bioequivalent, Not BE, BW BioWaiver, In Process, TBD

Distribution & Logistics

We have a robust distribution and logistics network that ensures our products are delivered efficiently and reliably to our customers.Inventory Management

We use advanced inventory management systems to optimize stock levels and ensure timely product availability to meet customer demand.

Transportation & Warehousing

We partner with reliable transportation and warehousing providers to ensure the safe and secure delivery of our products.

Pricing & Terms


Better, Best packages

We offer competitive pricing and flexible payment terms to our European customers.competitive pricing for our products to ensure they are accessible to patients and healthcare providers.

Flexible Payment Terms

We offer flexible payment terms to suit the needs of our customers, including net 30 and other options.

Transparent Pricing

We provide transparent pricing information and documentation to our customers, ensuring a clear understanding of our pricing structure.

Let Us Shape a healthy future together

We at RV Group are proud that our products are proven effective, safe and of high quality with good differentiation points. Currently they are registered and marketed in quiet a few countries. Based on our partner's plan and need, the products can be registered in additional countries in EU and the rest of the World.

From manufacturing to commercialization at RV group, through a collaborative business approach with you, we are achieving advances in treatment that effectively addresses the unmet needs of patients.

TEAM CONTACT

Rajiv Kumar Sharma (Mr.)

Director

rajiv@rv-health.com

Sudeshna Pan (Dr.)

General Director

sudeshna@rv-health.com

Dao Thi Kim Loan (Ms.)

CEO

loandao@rv-health.com

Animesh Tyagi (Mr.)

Chief Of Operations

animesh@rv-health.com

Shiuli Mukherji (Ms.)

Business Devleopment Manager

shiuli@rv-health.com

Quan Ai Nhu (Ms.)

Head of Legal Department

nhu.quan@rv-health.com

Digambar Rajaram Bugdikattikar (Mr.)

Head Of Regulatory

digambar@rv-health.com

Rijul Sharma(Mr.)

Director

rijul@rv-health.com

Namita Shirke (Ms.)

Chief Regulatory Officer

namita@rv-health.com

Bharat Shah (Mr.)

Director - Business Development

bharat@rv-health.com

Haidar Ali Shaikh(Mr.)

Manager- International Business

haidar@rvlifesciences.com

Ranjit Sen(Mr.)

Chief Business Officer

ranjit.sen@rv-health.com

Ajay Dhingra (Mr.)

Director Philippines

ajay@rv-health.com

Mahantesh Belle (Mr.)

Business Development Manager

mahantesh@rvlifesciences.com

Sugata Bhattacharya(Dr.)

Director

sugata@rv-health.com